On this page

Home > Topics > patient-reported outcomes; pro

patient-reported outcomes; pros; ema; us fda; health canada

Explore "patient-reported outcomes; pros; ema; us fda; health canada" with insightful episodes like and "PROs in regulatory decision making" from podcasts like " and "The Lancet Oncology in conversation with"" and more!

Episodes (1)

PROs in regulatory decision making

PROs in regulatory decision making

Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

The Lancet Oncology in conversation with

enApril 25, 2018

patient-reported outcomes; pros; ema; us fda; health canada

© 2024 Podcastworld. All rights reserved

Company

About us Blog Pricing Testimonials

Pages

Podcasts Episodes Topics

Support

Refund Policy Terms of Service Contact us Privacy Policy

Stay up to date

For any inquiries, please email us at hello@podcastworld.io